Viome acquires Sōlaria Biō for consumer synbiotics
PRIVATEOct 01, 2026
Acquiring Company
Viome
Acquired Company
Solarea Bio
BellevueWalthamOtherBiotechnologyHealth CareScience And EngineeringGeneticsBiotechnology
Description
Viome has announced its acquisition of Sōlaria Biō, a company specializing in clinically validated synbiotics and medical foods. This acquisition aims to combine Sōlaria's proprietary discovery platform with Viome's microbiome dataset. The goal is to develop targeted, condition-specific health products for consumers.
Company Information
Company
Viome
Location
Bellevue, Washington, United States
About
Viome is a pioneering longevity and preventive healthcare company committed to bridging the gap between scientific breakthroughs and their practical implementation as health solutions. Utilizing cutting-edge AI and the world's largest gene expression database, Viome's home-based tests offer individuals personalized nutritional guidance and innovative microbiome health products to enhance lifespan and health.
Viome has empowered over half a million users with its unique approach that marries groundbreaking proprietary RNA sequencing methods with AI technology. This combination analyzes epigenetic biomarkers, providing robust, AI-driven health insights that contribute significantly to promoting a healthy lifespan.
With its top-tier precision nutrition recommendations, Viome offers a comprehensive and personalized solution to aging - at its optimum. This is more than just health optimization; it's a revolution in understanding how we age and enabling us to do so with vitality and wellness.
Fundz sees it the moment Viome makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Solarea Bio was acquired by Viome, based in Bellevue. The deal was reported on October 1, 2026. Viome is a pioneering longevity and preventive healthcare company committed to bridging the gap between scientific breakthroughs and their practical implementation as health solutions. Viome is privately held and operates in Other.
When did Viome acquire Solarea Bio?
Viome's acquisition of Solarea Bio was reported on October 1, 2026. Viome has announced its acquisition of Sōlaria Biō, a company specializing in clinically validated synbiotics and medical foods. This acquisition aims to combine Sōlaria's proprietary discovery platform with Viome's microbiome dataset. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Solarea Bio do?
Solarea Bio is a biotechnology company based in Waltham, MA, that's committed to advancing the future of aging and measurably improving collective health outcomes. It is privately held, operating in Biotechnology, and is based in Waltham.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
Bellevue